XML 33 R17.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Note 11 - Stockholders' Equity | 12 Months Ended
--- | ---
Dec. 31, 2015
Notes to Financial Statements |
Shareholders' Equity and Share-based Payments [Text Block] | NOTE 1 1 – Stockholders’ equity 1989 Non-Qualified Stock Option Plan On June 15, 1989, the Company instituted a non-qualified stock option plan (the “Plan”). In connection therewith, 700,000 shares of the Company’s common stock were reserved for issuance pursuant to options granted under the Plan through June 30, 2009. All options granted vested over a four-year period and expire between five to seven years after the date of grant. This 1989 Non-Qualified Stock Option Plan expired in June 2009. 2001 Non-Qualified Stock Option Plan In November 2006, the Company registered a non-qualified stock option plan that the shareholders had approved in July 2001, covering key employees, officers, directors and other persons that may be considered as service providers to the Company. Options were awarded by the Board of Directors or by a committee appointed by the Board. Under the plan, an aggregate of 300,000 shares of Company common stock, $.01 par value, were reserved for issuance or transfer upon the exercise of options which were granted. Unless otherwise provided in the option agreement, options granted under the plan would vest over a four year period commencing one year from the anniversary date of the grant. The stock option plan expired on July 22, 2011. 2007 Share Incentive Plan On December 12, 2007, shareholders approved the Company’s 2007 Share Incentive Plan (“Incentive Plan”), in connection therewith, 750,000 shares of the Company’s common stock are reserved for issuance pursuant to options or restricted stock that may be granted under the Share Incentive Plan through December 12, 2017. In 2014, 42,320 shares of stock were granted and issued to directors and key employees, additionally, options were granted to a key employee for 100,000 shares of the Company’s common stock. In 2015, 36,108 shares of stock were granted and issued to directors and key employees. The purchase price of the common stock under each option plan shall be determined by the Committee, provided, however, that such purchase price shall not be less than the fair market value of the shares on the date such option is granted. The stock options generally expire seven to ten years after the date of grant. The Company recorded stock-based compensation of $750,758 and $515,933 for the years ended December 31, 2015 and 2014, respectively. A summary of the stock option activity related to the 1989 and 2001 Stock Option Plans and the 2007 Share Incentive Plan for the period from January 1, 2014 through December 31, 2015 is as follows: 1989 Non-Qualified Stock Option Plan
|  | Beginning Balance Outstanding |  |  | Granted During Period |  |  | Exercised During Period |  |  | Canceled During Period |  |  | Ending Balance Outstanding |  |  | Exercisable |
Year ended December 31, 2014 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares |  |  | 35,250 |  |  |  | -0- |  |  |  | -0- |  |  |  | 0 |  |  |  | 35,250 |  |  |  | 35,250 |
Weighted average exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share |  | $ | 4.62 |  |  |  | -0- |  |  |  | -0- |  |  |  | -0- |  |  | $ | 4.62 |  |  | $ | 4.62 |
Year ended December 31, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares |  |  | 35,250 |  |  |  | -0- |  |  |  | -0- |  |  |  | -0- |  |  |  | 35,250 |  |  |  | 35,250 |
Weighted average exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share |  | $ | 4.62 |  |  |  | -0- |  |  |  | -0- |  |  |  | -0- |  |  | $ | 4.62 |  |  | $ | 4.62 |
2001 Non-Qualified Stock Option Plan
|  | Beginning Balance Outstanding |  |  | Granted During Period |  |  | Exercised During Period |  |  | Canceled During Period |  |  | Ending Balance Outstanding |  |  | Exercisable |
Year ended December 31, 2014 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares |  |  | 152,480 |  |  |  | -0- |  |  |  | 28,000 |  |  |  | -0- |  |  |  | 124,480 |  |  |  | 111,980 |
Weighted average exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share |  | $ | 4.35 |  |  |  | -0- |  |  |  | -0- |  |  |  | -0- |  |  | $ | 4.57 |  |  | $ | 4.56 |
Year ended December 31, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares |  |  | 124,480 |  |  |  | -0- |  |  |  | -0- |  |  |  | -0- |  |  |  | 124,480 |  |  |  | 111,980 |
Weighted average exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share |  | $ | 4.35 |  |  |  | -0- |  |  |  | -0- |  |  |  | -0- |  |  | $ | 4.57 |  |  | $ | 4.56 |
2007 Share Incentive Plan
|  | Beginning Balance Outstanding |  |  | Granted During Period |  |  | Exercised During Period |  |  | Canceled During Period |  |  | Ending Balance Outstanding |  |  | Exercisable |
Year ended December 31, 2014 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares |  |  | -0- |  |  |  | 100,000 |  |  |  | -0- |  |  |  | -0- |  |  |  | 100,000 |  |  |  | -0- |
Weighted average exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share |  | $ | 11.17 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Year ended December 31, 2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares |  |  | 100,000 |  |  |  | -0- |  |  |  | -0- |  |  |  | -0- |  |  |  | 100,000 |  |  |  | -0- |
Weighted average exercise price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 11.17 |  |  |  |  |
The Company has 259,730 of outstanding stock options under the three Plans at December 31, 2015. The following table summarizes information about the outstanding and exercisable options at December 31, 2015.
|  |  |  |  |  | Options Outstanding |  |  |  |  |  |  |  |  |  |  | Options Exercisable |  |  |  |  |
Exercise Price Range |  |  | Number Outstanding |  |  | Weighted Average Remaining Contractual |  |  | Weighted Average Exercise Price |  |  | Intrinsic Value |  |  | Number Exercisable |  |  | Weighted Average Exercise Price |  |  | Intrinsic Value |
$ | 3.00 | - | 3.99 |  |  |  | 34,000 |  |  |  | 2.95 |  |  | $ | 3.65 |  |  | $ | 218,620 |  |  |  | 34,000 |  |  | $ | 3.65 |  |  | $ | 218,620 |
$ | 4.00 | - | 4.49 |  |  |  | 15,930 |  |  |  | 5.04 |  |  | $ | 4.25 |  |  | $ | 92,872 |  |  |  | 15,930 |  |  | $ | 4.25 |  |  | $ | 92,872 |
$ | 4.50 | - | 4.99 |  |  |  | 100,000 |  |  |  | 2.78 |  |  | $ | 4.62 |  |  | $ | 546,000 |  |  |  | 75,000 |  |  | $ | 4.62 |  |  | $ | 546,000 |
$ | 5.00 | - | 7.99 |  |  |  | 9,800 |  |  |  | 6.04 |  |  | $ | 7.90 |  |  | $ | 21,364 |  |  |  | 9,800 |  |  | $ | 7.90 |  |  | $ | 21,364 |
$ | 8.00 | - | 12.00 |  |  |  | 100,000 |  |  |  | 9.80 |  |  | $ | 11.17 |  |  | $ | 0 |  |  |  | 0 |  |  | $ | 11.17 |  |  | $ | 0 |
There were no options exercised during the year ended December 31, 2015. The intrinsic value of the 28,000 options exercised during the year ended December 31, 2014 was $310,520. Restricted Stock Awards The following table summarizes restricted stock awards for the year ended December 31, 2014:
|  | Shares of Restricted Stock |  |  | Weighted Average Grant Date Fair Value |
Unvested outstanding at January 1, 2014 |  |  | 12,000 |  |  | $ | 10.97 |
Granted |  |  | 6,400 |  |  | $ | 14.24 |
Vested |  |  | (10,400 | ) |  | $ | 12.98 |
Forfeited/Cancelled |  |  | - |  |  |  |  |
Unvested outstanding at December 31, 2014 |  |  | 8,000 |  |  | $ | 10.97 |
Granted |  |  | 9,211 |  |  | $ | 13.66 |
Vested |  |  | (13,211 | ) |  | $ | 12.84 |
Forfeited/Cancelled |  |  | - |  |  |  |  |
Unvested outstanding at December 31, 2015 |  |  | 4,000 |  |  | $ | 10.97 |
The total fair value of shares of restricted stock awards vested for the years ended December 31, 2015 and 2014 was approximately $170,000 and $135,000 respectively. The fair value of the outstanding restricted stock awards will be recorded as stock compensation expense over the vesting period. As of December 31, 2015 there was $44,000 of unrecognized compensation costs related to restricted stock awards, which is to be recognized over a period of 0.35 years. Restricted Stock Units The following table summarizes restricted stock units for the year ended December 31, 2015:
|  | Shares of Restricted Stock Units |  |  | Weighted Average Grant Date Fair Value |
Unvested outstanding at January 1, 2014 |  |  | 144,243 |  |  | $ | 11.26 |
Granted |  |  | -- |  |  |  |  |
Vested |  |  | (37,925 | ) |  | $ | 10.09 |
Forfeited/Cancelled |  |  | (2,500 | ) |  | $ | 10.71 |
Unvested outstanding at December 31, 2014 |  |  | 103,319 |  |  | $ | 11.71 |
Granted |  |  | 24,210 |  |  | $ | 14.61 |
Vested |  |  | (24,892 | ) |  | $ | 11.55 |
Forfeited/Cancelled |  |  | (8,057 | ) |  | $ | 10.54 |
Unvested outstanding at December 31, 2015 |  |  | 94,580 |  |  | $ | 12.55 |
The total fair value of vested restricted stock units was $288,000 and $383,000 respectively for the years ended December 31, 2015 and 2014. The fair value of the outstanding restricted stock units will be recorded as stock compensation expense over the vesting period. As of December 31, 2015, there was $1,187,000 of total unrecognized compensation costs related to restricted stock units, which is expected to be recognized over a weighted-average period of 1.53 years. During the years ended December 31, 2015 and 2014, the Company recorded into selling and general administrative expense approximately $751,000 and $516,000 for the cost of employee and director services received in exchange for equity instruments based on the grant-date fair value of those instruments in accordance with the provisions of ASC 718.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details. + References No definition available. + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration